Prometheus Biosciences, Inc. RXDX
199.92 +199.92
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| 6.81M | 3.13M | 1.23M | 1.12M | |
| 6.81M | 3.13M | 1.23M | 1.12M | |
| -145.78M | -87.80M | -29.01M | -15.97M | |
| -141.75M | -90.19M | -37.14M | -29.72M | |
| -3.49 | -2.88 | -24.78 | -26.47 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| 292.42M | 257.25M | 54.20M | 4.45M | |
| 740.77M | 267.80M | 59.63M | 50.48M | |
| 64.81M | 32.65M | 31.15M | 43.71M | |
| 29.54M | 0 | 7.40M | 0 | |
| 675.97M | 235.16M | -97.54M | -36.97M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| -123.25M | -63.51M | -28.02M | -20.20M | |
| -403.78M | -1.14M | -1.06M | 7.93M | |
| 562.20M | 267.69M | 79.89M | 9.76M | |
| -2.70M | -1.14M | -204.00K | -279.00K | |
| 35.17M | 203.05M | 50.80M | -2.51M |